Psychoactive drug DMT (aka N, N-Dimethyltryptamine) is known for its life-altering, metaphysical trips, but scientists are now looking into its potential to treat depression. Small Pharma, a Canadian drug development company, is working on combining DMT with regular therapy to ease depression in treatment-resistant patients. In September, the company completed phase one of clinical trials—the first company to do so—by testing DMT on volunteers. Now, …
Excision Biotherapeutics’ groundbreaking HIV treatment, EBT-101, was approved by the Food and Drug Administration to begin testing for its first phase of human trials. This new treatment relies on the Nobel Prize-winning, gene-editing technology CRISPR to successfully remove HIV proviral DNA from human cells. Scientists believe that this one-time treatment will “functionally cure” people from the virus, meaning only small traces of the HIV genome …
GLAAD’s #TransLoveStories Portraits for Transgender Day of Visibility 31 March marked the 10th annual Transgender Day of Visibility (TDOV), observed worldwide to celebrate trans people everywhere. Representation is vital, always, and especially when it portrays trans individuals finding and sharing love. To honor the occasion, GLAAD is highlighting relationships in the trans community through their #TransLoveStories campaign. NYC-based photographer Landyn Pan captured tender moments through …
